Novartis division Sandoz recalls one lot of blood pressure drug

Nov 09, 2018 , Reuters
Novartis said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug.

Read the full story...

Trending healthcare news keywords at this moment

women drug cancer study time finds heart patients risk states medical tip safe opioid disease care hospital digital food test media kids cvs state tied outbreak people fda push young blood generic report focalin